SCHEMBL8905735

SCHEMBL8905735

CCCCCCCCCCCCCCCCCC(=O)OC1=C(C)OC(CC)C1=O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 7/20 0.41
MAPT P10636 2/20 0.41
RECQL P46063 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
HSPD1 P10809 1/20 0.41
HSPE1 P61604 1/20 0.41
TST Q16762 1/20 0.41
BLM P54132 1/20 0.41
PTPN1 P18031 4/20 0.40
ACP1 P24666 2/20 0.40
CDC25B P30305 2/20 0.40
PTPN2 P17706 1/20 0.40
DUSP3 P51452 1/20 0.40
HPSE Q9Y251 1/20 0.40
POLM Q9NP87 1/20 0.40
POLK Q9UBT6 1/20 0.40
POLL Q9UGP5 1/20 0.40
POLH Q9Y253 1/20 0.40
DGKA P23743 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8905325 1.00 PRKCA (0.41) PRKCAMAPTRECQLTDP1HSPD1
SCHEMBL8905344 1.00 PRKCA (0.41) PRKCAMAPTRECQLTDP1HSPD1
SCHEMBL8905727 1.00 PRKCA (0.41) PRKCAMAPTRECQLTDP1HSPD1
SCHEMBL8905186 1.00 PRKCA (0.41) PRKCAMAPTRECQLTDP1HSPD1
SCHEMBL8905907 1.00 PRKCA (0.41) PRKCAMAPTRECQLTDP1HSPD1
SCHEMBL8904013 1.00 PRKCA (0.41) PRKCAMAPTRECQLTDP1HSPD1
SCHEMBL8906517 1.00 PRKCA (0.41) PRKCAMAPTRECQLTDP1HSPD1
SCHEMBL8904855 1.00 PRKCA (0.41) PRKCAMAPTRECQLTDP1HSPD1
SCHEMBL8905003 1.00 PRKCA (0.41) PRKCAMAPTRECQLTDP1HSPD1
SCHEMBL8903985 1.00 PRKCA (0.41) PRKCAMAPTRECQLTDP1HSPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5698585-A FOR SENILE CATARACT CAUSED BY OXIDATION DISORDER; VISION DEFECTS KIKKOMAN CORPORATION (JP) 1997-12-16 US disclosed
EP-0737476-A2 A pharmaceutical preparation containing a 3-(2H)-furanone derivative for prevention and/or treatment of cataracts KIKKOMAN CORPORATION (JP) 1996-10-16 EP disclosed